_____ is the first chemokine coreceptor (CCR5) antagonist approved for use in HAART.
a) Enfuvirtide (Fuzeon)
b) Etravirine (Intelence)
c) Nelfinavir (Viracept)
d) Maraviroc (Selzentry)